by Rachel LaBreck | Jun 25, 2024 | News
Dental Economics recently featured Vigilant Biosciences® and our BeVigilant™ OraFusion™ System in an article highlighting advancements in early oral cancer detection. The OraFusion System is a real-time, saliva-based test that enables dental professionals to identify...
by Rachel LaBreck | Jun 10, 2024 | News
We’re thrilled to see the BeVigilant™ OraFusion™ System featured in DSOPro as a key innovation shaping the future of DSOs. The article highlights how the BeVigilant™ OraFusion™ System enables clinicians to detect early signs of oral cancer in real-time, right from the...
by Rachel LaBreck | May 3, 2024 | News
We’re excited to see Dental Products Report highlight the BeVigilant™ OraFusion™ System as a powerful advancement in oral cancer detection. The article dives into how our technology leverages salivary biomarkers and AI to deliver real-time results chairside—giving...
by dex.manley | Nov 15, 2023 | News
Lifestyle factors play a major role in the development of oral cancer. Among the many clinical risk factors, smoking and alcohol top the list of behaviors that most directly increase a patient’s risk of oral cancer. Alone, smoking increases oral cancer risk by ten...
by dex.manley | Nov 9, 2023 | News
Lakeway, Texas (Date: 11-9-2023) – Vigilant Biosciences®, Inc. (“Vigilant”), an innovator and creator of solutions aimed at facilitating the early detection of oral cancer, is proud to announce the launch of its transformative product, the BeVigilant™...
by dex.manley | Oct 10, 2023 | News
As a pioneer in early oral cancer detection solutions, Vigilant Biosciences® strives to help clinicians diagnose oral cancer in Stages I and II to accelerate treatment initiation and improve patient outcomes. Our team leverages decades of specialized clinical...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES